SCHEMBL17103166

SCHEMBL17103166

CC(Cl)COn1nnc2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.58
NPSR1 Q6W5P4 1/20 0.58
RXFP1 Q9HBX9 1/20 0.58
KMT2A Q03164 5/20 0.55
SMN1; SMN2 Q16637 3/20 0.50
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
HPGD P15428 1/20 0.49
MAPT P10636 1/20 0.46
SLC9A1 P19634 4/20 0.44
HTT P42858 1/20 0.44
ALDH1A1 P00352 1/20 0.43
KEAP1 Q14145 1/20 0.43
BRD4 O60885 1/20 0.42
GRM2 Q14416 1/20 0.41
POLB P06746 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17103040 0.81 KMT2A (0.46) TSHRNPSR1RXFP1KMT2ASMN1; SMN2
SCHEMBL4006352 0.78 TSHR (0.67) TSHRNPSR1RXFP1KMT2ASMN1; SMN2
SCHEMBL17664888 0.78 TSHR (0.58) TSHRNPSR1RXFP1KMT2ASMN1; SMN2
SCHEMBL17663546 0.77 TSHR (0.56) TSHRNPSR1RXFP1KMT2ASMN1; SMN2
SCHEMBL6697985 0.76 TSHR (0.55) TSHRNPSR1RXFP1KMT2ASMN1; SMN2
SCHEMBL17103103 0.76 TSHR (0.63) TSHRNPSR1RXFP1KMT2ASMN1; SMN2
SCHEMBL9483441 0.76 TSHR (0.63) TSHRNPSR1RXFP1KMT2ASMN1; SMN2
SCHEMBL23146639 0.75 TSHR (0.67) TSHRNPSR1RXFP1KMT2ASMN1; SMN2
SCHEMBL9612373 0.75 TSHR (0.53) TSHRNPSR1RXFP1KMT2ASMN1; SMN2
SCHEMBL17103078 0.75 TSHR (0.67) TSHRNPSR1RXFP1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9802929-B2 Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof SHENYANG HAIWANG BIOTECHNOLOGY CO., LTD. (CN) 2017-10-31 US disclosed
US-9415047-B2 Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives Liaoning Emmy Biological Pharmaceutical Co., Ltd. (CN) 2016-08-16 US disclosed
US-20160009703-A1 BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERIDINE OR PIPERAZINE DERIVATIVES AND PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS THEREOF LIAONING EMMY BIOLOGICAL PHARMACEUTICAL CO., LTD (CN) 2016-01-14 US disclosed
US-20150297586-A1 USE OF BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERAZINE OR PIPERIDINE DERIVATIVES Liaoning Emmy Biological Pharmaceutical Co., Ltd. (CN) 2015-10-22 US disclosed
EP-2924032-A1 BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERIDINE OR PIPERAZINE DERIVATIVES AND PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS THEREOF Liaoning Emmy Biological Pharmaceutical Co., Ltd (CN) 2015-09-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150297586-A1 USE OF BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERAZINE OR PIPERIDINE DERIVATIVES P2RX5, TBXA2R, CYP3A5 TSHR 2743/4885NPSR1 21/4885RXFP1 139/4885
US-20160009703-A1 BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERIDINE OR PIPERAZINE DERIVATIVES AND PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS THEREOF CYP3A5, IL5, ABCC5 TSHR 1880/4885NPSR1 75/4885RXFP1 557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.